Amides of fatty acids with ethanolamine (FAE) are biologically active lipids that participate in a variety of biological functions, including the regulation of feeding. The polyunsaturated FAE anandamide (arachidonoylethanolamide) increases food intake by activating G proteincoupled cannabinoid receptors. On the other hand, the monounsaturated FAE oleoylethanolamide (OEA) reduces feeding and body weight gain by activating the nuclear receptor PPAR-␣ (peroxisome proliferator-activated receptor ␣). In the present report, we examined whether OEA can also influence energy utilization. OEA (1-20 M) stimulated glycerol and fatty acid release from freshly dissociated rat adipocytes in a concentration-dependent and structurally selective manner. Under the same conditions, OEA had no effect on glucose uptake or oxidation. OEA enhanced fatty acid oxidation in skeletal muscle strips, dissociated hepatocytes, and primary cardiomyocyte cultures. Administration of OEA in vivo (5 mg kg ؊1 , intraperitoneally) produced lipolysis in both rats and wild-type mice, but not in mice in which PPAR-␣ had been deleted by homologous recombination (PPAR-␣ ؊/؊ ). Likewise, OEA was unable to enhance lipolysis in adipocytes or stimulate fatty acid oxidation in skeletal muscle strips isolated from PPAR-␣ mice. The synthetic PPAR-␣ agonist Wy-14643 produced similar effects, which also were dependent on the presence of PPAR-␣. Subchronic treatment with OEA reduced body weight gain and triacylglycerol content in liver and adipose tissue of dietinduced obese rats and wild-type mice, but not in obese PPAR-␣ ؊/؊ mice. The results suggest that OEA stimulates fat utilization through activation of PPAR-␣ and that this effect may contribute to its anti-obesity actions.Amides of long-chain fatty acids with ethanolamine (FAE) 1 are a family of lipid mediators produced through the concerted action of two enzymes present in mammalian cells: N-acyltransferase, which transfers a fatty acid from the sn-1 position of a donor phospholipid to the free amine in phosphatidylethanolamine, producing N-acyl-phosphatidylethanolamine; and phospholipase D, which converts N-acyl-phosphatidylethanolamine to FAE (1, 2). The FAE are hydrolyzed intracellularly to fatty acids and ethanolamine by the action of fatty acid amide hydrolase enzymes (3)(4)(5).Although the FAE were first described four decades ago (6), they did not attract much attention until the discovery that a polyunsaturated member of this family, anandamide (arachidonoylethanolamide), is an endogenous ligand for cannabinoid receptors, G protein-coupled receptors targeted by the marijuana constituent ⌬ 9 -tetrahydrocannabinol (7). Anandamide is now established as a brain endocannabinoid messenger (8) and multiple roles for other FAE have also been proposed (9 -11). One emerging function of these lipid mediators is the regulation of feeding behavior. Anandamide causes overeating in rats because of its ability to activate cannabinoid receptors (12). This action is of therapeutic relevance: cannabinoid agonists su...